Skip to main content

Table 3 Acceptability of the PDA scored by both patients and healthcare providers

From: Development and alpha-testing of a patient decision aid for patients with chronic myeloid leukemia regarding dose reduction

Acceptability item

Patients (n = 17)

HCP (n = 9)

Time spent in minutes, mean (SD)

9.7 (7.8)

10.6 (3.9)

Length

  

 Too long

 Just right

 Too short

2 (11.8%)

14 (82.4%)

1 (5.9%)

1 (11.1%)

8 (88.9%)

-

Amount of information

  

 Too little

 Just right

 Too much

1 (5.9%)

15 (88.2%)

1 (5.9%)

-

7 (77.8%)

2 (22.2%)

Information balanced?

  

 Yes

 No, favoring dose reduction

 No, favoring no dose reduction

14 (82.4%)

3 (17.6%)

-

5 (55.6%)

2 (22.2%)

2 (22.2%)

General comprehensibility PDA

  

 Good

 Average

 Poor

15 (88.2%)

1 (5.9%)

1 (5.9%)

8 (88.9%)

1 (11.1%)

-

Are potential disadvantages of dose reduction comprehensible?

  

 Good

 Average

 Poor

 I miss this information

14 (82.4%)

-

2 (11.8%)

1 (5.9%)

8 (88.9%)

1 (11.1%)

-

-

Is the information appropriate for patients?

  

 Good

 Average

 Poor

15 (88.2%)

-

2 (11.8%)

7 (77.8%)

2 (22.2%)

-

How is the navigation through the PDA?

  

 Easy

 Neutral

 Difficult

14 (82.4%)

1 (5.9%)

2 (11.8%)

9 (100%)

-

-

The PDA consists confusing items (yes)

3 (17.6%)

3 (33.3%)

The personal value clarification step…

  

 Made the choice easier

 Made the choice harder

 Does not influence my choice

4 (23.5%)

-

13 (76.5%)

8 (88.9%)

-

1 (11.1%)

The PDA is helpful in decision-making (yes)

11 (64.7%)

8 (88.9%)

The PDA has enough information to make a decision (yes)

16 (82.4%)

7 (77.8%)

Score on a scale 1–10 (mean, SD)

7.4 (1.6)

7.8 (0.7)

Recommend the use of the PDA (yes)

13 (76.5%)

9 (100%)